Abstract
Regulatory compliance is often perceived to be in conflict with business success and profitability. In many cases this perception cascades down through the ranks, resulting in meeting only the letter of the law of the regulations without satisfying their intent. This in turn generates further problems that can ultimately lead to non-compliance and/or product failure with a negative impact on the patient, both in health risks and high costs of medication. In the end the conflict between regulatory and business generates risk for every facet of the health care system: patients, regulatory, and industry.
This paper proposes a risk/science-based strategy for “validation” using design of experiments that will be viewed as a victory for all—patients, regulators, and industry—a win-win-win. This strategy offers vital assurance that regulatory will see no degradation of previous expectations, while affording business leaders a high level of confidence that compliance can also reduce waste within the business and therefore positively affect the bottom line. Science-based validation supports new FDA views outlined in a new Draft Guidance for Industry, PAT–A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance, published August 2003. Patients can ultimately expect benefits in improved quality and lower cost. In short, the three-fold goals of this strategy are to achieve compliance to regulations, combined with return on investment (ROI) to industry, and lower health risks and costs to the patient.
- Science-based validation
- Prospective
- Retrospective
- Design of experiments (DOE)
- Critical quality attributes
- Key process input variables
- Scale-up calibration
- Return on investment
- Process analytical technology (PAT)
- New cGMPs of the 21st century: a risk-based approach
Footnotes
- Copyright © Parenteral Drug Association. All rights reserved.
PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.
If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing.
Full issue PDFs are for PDA members only.
Note to pda.org users
The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.